loading animation for AJAX calls
Items per page:   25 | 50 | 75 | 100

167 Reports in Pharmaceuticals

Laboratory Animal Models, 3D Cultures and Organoids

Published - Apr 2019 | Analyst - Martin Kubeš| Code - PHM204A

The global market for laboratory animal models should grow from $5.9 billion in 2018 to $7.8 billion by 2023, increasing at a compound annual growth rate (CAGR) of 5.6% for the period of 2018-2023.

2018 Pharmaceuticals Research Review

Published - Mar 2019 | Analyst - Various Analysts| Code - PHM099F

2018 Pharmaceuticals Research Review provides a sampling of the type of quantitative market information, analysis and guidance that has been aiding business decision making.

Laboratory Automation Systems and Processes: Global Markets and T...

Published - Mar 2019 | Analyst - Todd Graham| Code - PHM201A

The global market for laboratory automation systems and processes should grow from $21.1 billion in 2018 to reach $29.2 billion by 2023 at a compound annual growth rate (CAGR) of 6.8% for the period of 2018-2023.

In Vitro Toxicity Testing: Technologies and Global Markets

Published - Feb 2019 | Analyst - Anuj Pathak| Code - PHM017F

The global market for in vitro toxicity testing should grow from $7.4 billion in 2018 to reach $10.4 billion by 2023 at a compound annual growth rate (CAGR) of 7.1% for the period of 2018-2023.

High-Throughput Screening: Technologies and Global Markets

Published - Feb 2019 | Analyst - Anuj Pathak| Code - PHM205A

The global high-throughput screening (HTS) market should reach $21.1 billion by 2023 from $14.4 billion in 2018 at a compound annual growth rate (CAGR) of 7.9% for the period 2018-2023.

Blood Cancer Therapeutics: Global Markets to 2023

Published - Jan 2019 | Analyst - BCC Research Staff| Code - PHM210A

The global market for blood cancer therapeutics should grow from $38.5 billion in 2018 to $64.8 billion by 2023 at a compound annual growth rate (CAGR) of 11.0% from 2018 to 2023.

Brain Tumor Therapeutics: Global Markets to 2023

Published - Jan 2019 | Analyst - BCC Research Staff| Code - PHM208A

The global market for brain tumor therapeutics should grow from $1.1 billion in 2018 to reach $2.0 billion by 2023 at a compound annual growth rate (CAGR) of 12.9% for the period of 2018-2023.

Global Cancer Therapeutics Market: Emphasis on Recurrent and Meta...

Published - Jan 2019 | Analyst - BCC Research Staff| Code - PHM177B

The global cancer therapeutics market should grow from $128.1 billion in 2018 to $182.0 billion by 2023 at a compound annual growth rate (CAGR) of 7.3% for the period of 2018-2023.

Global Market for Contract Research Organization (CRO) Services

Published - Dec 2018 | Analyst - David Christofides| Code - PHM186A

The global market for CRO's across the clinical trial process should grow from $45.5 billion in 2017 to reach $72.3 billion by 2022 at a compound annual growth rate (CAGR) of 9.7% for the period of 2017-2022.

Opioid Drugs: Global Markets to 2023

Published - Dec 2018 | Analyst - BCC Research Staff| Code - PHM207A

The global market for opioid drugs should reach $29.8 billion by 2023 from $26.4 billion in 2018 at a compound annual growth rate (CAGR) of 2.5% for the period of 2018-2023.

Antibiotics: Global Markets to 2023

Published - Dec 2018 | Analyst - BCC Research Reference Staff| Code - PHM209A

The global antibiotics market should reach $55.8 billion by 2023 from $38.3 billion in 2018 at a compound annual growth rate (CAGR) of 7.8% for the period of 2018-2023.

Lung Cancer Therapeutics: Global Markets

Published - Dec 2018 | Analyst - BCC Research Staff| Code - PHM206A

The global market for lung cancer therapeutics should grow from $17.9 billion in 2018 to $26.3 billion by 2023, increasing at a compound annual growth rate (CAGR) of 8.0% from 2018 to 2023.

Diagnostics and Therapeutics for HIV: Global Markets

Published - Nov 2018 | Analyst - BCC Research Staff| Code - PHM058C

The global HIV therapeutics market should reach $27.1 billion by 2023 from $22.0 billion in 2018 at a compound annual growth rate (CAGR) of 4.3% for the period of 2018 to 2023.

Checkpoint Inhibitors: Global Markets

Published - Nov 2018 | Analyst - Dr. Cheryl Lee Barton| Code - PHM185A

The global checkpoint inhibitors market should reach $29.3 billion by 2023 from $14.9 billion in 2018 at a compound annual growth rate (CAGR) of 14.4% for the period of 2018-2023.

Global Viral Vector Manufacturing Markets and Technologies Throug...

Published - Nov 2018 | Analyst - Vijay Laxmi| Code - PHM172A

The global market for viral vector vaccine manufacturing is expected to increase from $22.9 million in 2017 to nearly $51.2 million in 2022 at a compound annual growth rate (CAGR) of 17.5% for 2017-2022.

Antipsychotic Drugs: Technologies and Global Markets

Published - Oct 2018 | Analyst - BCC Research Staff| Code - PHM063B

The global market for antipsychotic drugs should grow from $13.2 billion in 2018 to reach $14.5 billion by 2023 at a compound annual growth rate (CAGR) of 1.9% for the period of 2018-2023.

Lysosomal Disease Treatments: Technologies and Global Markets

Published - Oct 2018 | Analyst - Neha Maliwal| Code - PHM183A

The global market for lysosomal storage diseases treatment should grow from $5.1 billion in 2018 to reach $7.6 billion by 2023 at a compound annual growth rate (CAGR) of 8.3% for the period of 2018-2023.

Global Markets for Treatment and Diagnosis of Sexually Transmitte...

Published - Sep 2018 | Analyst - BCC Research Staff| Code - PHM005D

The global market for sexually transmitted disease therapeutics reached $52.0 billion in 2018 and should reach nearly $63.0 billion by 2023, at a compound annual growth rate (CAGR) of 3.9% for the period of 2018-2023.

Antiemetics: Technologies and Global Markets

Published - Aug 2018 | Analyst - BCC Research Staff| Code - PHM070B

The global market for antiemetics reached $4.1 billion in 2017 and should reach $5.9 billion by 2022, at a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2018-2023.

Pharmaceuticals for Women's Health: Global Markets to 2023

Published - Aug 2018 | Analyst - BCC Research Staff| Code - PHM203A

The global market for women’s health therapeutics reached nearly $30.5 billion in 2018 and should reach nearly $37.3 billion by 2023, at a compound annual growth rate (CAGR) of 4.2% for the period of 2018-2023. 

Cognition and Memory Enhancement Drugs: Technologies and Global M...

Published - Jul 2018 | Analyst - Sangeeta Rai| Code - PHM184A

The global cognition and memory-enhancing drugs market should reach over $4.2 billion by 2022 from $2.8 billion in 2017 at a compound annual growth rate (CAGR) of 8.7% for the period 2017-2022.

Active Pharmaceutical Ingredients: Global Markets to 2022

Published - Jul 2018 | Analyst - BCC Research Staff| Code - PHM200A

The global active pharmaceutical ingredient (API) market should reach $154.7 billion by 2022 from $114.2 billion in 2017 at a compound annual growth rate (CAGR) of 6.2% for the period 2017-2022.

Neuroprotective Agents: Therapeutic Applications and Global Marke...

Published - Jul 2018 | Analyst - Ufuk Ezer| Code - PHM188A

The global market for neuroprotective agents will grow from $54.4 billion in 2017 to $75.8 billion by 2022 with a compound annual growth rate (CAGR) of 6.8% for the period of 2017-2022.

Antiulcerant Drugs: Global Markets to 2022

Published - Jun 2018 | Analyst - BCC Research Reference Staff| Code - PHM202A

The global antiulcerant drugs market will grow from $33.0 billion in 2017 to $37.4 billion by 2022 with a compound annual growth rate (CAGR) of 2.5% for the period of 2017-2022.

Clinical Nutrition: Global Markets to 2022

Published - May 2018 | Analyst - BCC Research Staff| Code - PHM198A

The global clinical nutrition market should reach $60.8 billion by 2022 from $48.2 billion in 2017 at a compound annual growth rate (CAGR) of 4.8% for the period 2017-2022.

8 Upcoming Reports in Pharmaceuticals

Colorectal Cancer Therapeutics: Global Markets

Target Date - Mar 2019| Author - BCC Research Staff| Code - PHM211A| Price - $5,500

Report Includes

  • Detailed overview of the colorectal cancer (CRC) therapeutics and corresponding global markets
  • Country specific data and analysis for France, Germany, Italy, U.K., Spain, Russia, India, China, Japan, United States, Canada, Middle East and Africa
  • Evaluation of market dynamics with a focus on increasing prevalence of colorectal cancer cases, technological advancements in radiology and chemotherapy, and increasing cancer prevention initiatives
  • Coverage of some of the significant CRC tests including CT colonography, double-contrast barium enema, and biopsy test and their usability study and future growth potential
  • A look into regulatory environment, new products launces and technological advancements, and current strategies within the market
  • Company profiles of major manufacturers and suppliers of CRC therapeutic drugs

Notify Me

Drugs of Abuse Testing: Technologies and Global Markets

Target Date - Mar 2019| Author - BCC Research Staff| Code - PHM013H| Price - $5,500

Report Includes

  • An industry analysis of the global market for drug testing technologies within the pharmaceutical industry
  • Analyses of global market trends, with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Statistical information pertaining to drug abuse along with its trends as well as drug classes in key geographic regions
  • Information on leading players in the market and their key products
  • Sales projections through 2023 for drug of abuse testing markets by sample matrix and geographic regions
  • Technological assessment of the current and possible future legislation affecting the market in the U.S. and other emerging economies, and examines the influence of these acts in the development of the industry
  • Company profiles of major global players operating within the drug development market

Notify Me

Interleukin-2, a Tale of Two Halves: To Suppress or Augment Suppression, That is the Question

Target Date - Apr 2019| Author - Dr. Cheryl Lee Barton| Code - PHM212A| Price - $995

Report Includes

  • An introduction to interleukin-2 (IL-2) and identification of its applications
  • Insights of the latest trends and technologies in the IL-2 research and development
  • Discussion of strategies adopted by IL-2 developers for the successful treatment of cancer and information on NKTR-214, a Nektar Therapeutics product
  • Review of recent VC investment in this zone highlighted by Syncona and Novartis Venture Fund recent CHF35m investment in Anaveon AG, a new Swiss Biotech company spun out from the University of Zuirich which is developing a novel oncologic monoclonal antibody that boosts IL-2 but has an improved side-effect profile.
  • Detailed description of autoimmune responses and possible ways to augment immune responses so as to improve antitumor activity and reduce off target effect
  • An understanding of various conditions which may develop as an off-target effects in the cancer treatment such as metastatic melanoma (MM), renal cell carcinoma (RCC), urothelial cancers (US) relapse remitting multiple sclerosis (RRMS), and Type 1 diabetes (T1D)

Notify Me

Global Research and Development Investments in Over-the-Counter (OTC) Drugs and Nutraceuticals

Target Date - Apr 2019| Author - Anand Gijare| Code - PHM187A| Price - $4,950

Report Includes

  • An overview of the global research and development investments in over-the-counter (OTC) drugs and nutraceuticals.
  • Analyses of global market trends, with data from 2016, 2017, and projections of compound annual growth rates (CAGRs) through 2022.
  • Discussion of the strategies and plans behind research-and-development activities.
  • Estimation of investments in R&D activities in OTC drugs by therapeutic classification, routes of OTC drug administration, companies, institutions, and regions.
  • Macro- and micro-level scenarios, insights, and analyses of global R&D initiatives around OTC drugs.
  • Company profiles of key players in the industry based on their market shares, product offerings, and regions.

Notify Me

Pharmaceutical Pricing and Reimbursement: Global Markets

Target Date - Apr 2019| Author - Dr. Cheryl Lee Barton| Code - PHM189A| Price - $4,950

Report Includes

  • An overview of the global markets for pharmaceuticals, specifically healthcare legislation and regulation, pricing mechanisms, and reimbursement procedures.
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
  • Information on the current price and reimbursement landscape, benchmarking statics, and future development opportunities in the pharma industry.
  • Case studies of different price and reimbursement strategies for prescription drugs, generics, biosimilars, hospitals, and over-the-counter products.
  • Coverage of market dynamics, specifically growth drivers, restraints, and opportunities.
  • Comprehensive company profiles of major players in the industry.

Notify Me

Global Markets for Generic Drugs

Target Date - Apr 2019| Author - Paul Evers| Code - PHM009J| Price - $5,500

Report Includes

  • An overview of the global markets for generic drugs, including coverage of therapeutics such as antibacterials, antidepressants, anticancer agents, anti-arthritics, cardiovascular drugs (e.g., hypolipidaemics and antihypertensives), and drugs for respiratory conditions, including asthma and COPD.
  • Analyses of global market trends, with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023.
  • Examination of strategies employed by companies specializing in generics to meet the challenges of this highly competitive market, while also summarizing strategies employed by “originator” companies to forestall generic competition.
  • Discussion of important trends by product categories and major country markets, acknowledging that Brazil, China, India, Mexico, and Russia are among the rising markets for generic activity.
  • Profiles of major players and leading generics companies.
  • A look at recent merger-and-acquisition activity.

Notify Me

 
Get Notified when New Reports are published
MEMBERSHIP

 

CUSTOM